3632 results for «445»
3632 results
Integrating FFRangio into your daily practice - Empowering wire-free insights
18 May 2023 – From EuroPCR 2023
In this session, dive into the world of FFRangio, from concept to clinical reality, and then analyze different cases in real practice to see how useful the physiology is, to try to understand why it is still so little used, and to learn how FFRangio could...
Management of PCI complications
16 May 2023 – From EuroPCR 2023
Listen to speakers explore the landscape of PCI complications, dissecting their impact, strategies for skillful management and ways to optimize patient outcomes. Advance your own understanding of this important problem and discover a range of approaches to mitigating it.
Meaningful innovations in interventional cardiology
18 May 2023 – From EuroPCR 2023
In this session, watch the case of a 56-year-old man with HTN, DM, stable CAD, PFO and previous ischaemic stroke, who presented with severely calcified CTO lesion on proximal LAD and significant mid-RCA lesion, and find out how he was treated LIVE... among others!
Elixir Medical To Announce Late-Breaking Clinical Data at EuroPCR 2023 Session Featuring World’s First Transforming Coronary Artery Implant Designed to Restore Vessel Physiology and Function
09 May 2023
EuroPCR 2025: Late-breaking data demonstrate sustained significantly lower event rates with Elixir Medical’s DynamX® Bioadaptor over drug-eluting stent through three Years
21 May 2025
Promising Safety and Efficacy Results for Supraflex Cruz in HBR Subset Analysis from FIRE Trial, with 1-Month DAPT
03 Nov 2023
PCR and CRF Announce Partners in Learning Virtual Sessions
28 May 2020
NEW YORK – PCR and CRF are pleased to announce the creation of virtual Partners in Learning sessions that will be broadcast during the PCR e-Course (June 25-27, 2020 - #PCReCourse) and CRF’s TVT Connect meeting (June 18-28, 2020). The sessions, which will cover coronary artery...
A randomised, multicenter, non-inferiority comparison of intravascular lithotripsy and super-high-pressure non-compliant balloons for treatment of calcified and refractory coronary lesions - The VICTORY trial
25 Oct 2025
Mirvat Alasnag provides her take on the VICTORY trial presented by Matthias Bossard at TCT 2025 in San Francisco.
Author
Positive 3-year results from FIRE Trial demonstrate Supraflex Cruz’s safety and efficacy in elderly heart attack patients
26 Sep 2025
Elixir Medical’s DynamX Bioadaptor demonstrates significant improvement over contemporary drug-eluting stent in patients with acute coronary syndrome and complex lesion subsets after six months
28 Oct 2024
EuroPCR 2024: Late-breaking data demonstrate significant clinical advantage of Elixir Medical’s DynamX bioadaptor over standard-of-care drug-eluting stent at two years
14 May 2024
EuroPCR 2023: Late-Breaking Clinical Data Demonstrate Elixir Medical’s DynamX Bioadaptor Restores Vessel Motion and Function with Better Effectiveness at 12 Months Compared to a Leading Drug-Eluting Stent (DES)
17 May 2023